185 filings
Page 4 of 10
4
cr217qh7hqzsihg
27 Jan 23
Virpax Pharmaceuticals / Anthony P. Mack ownership change
8:30pm
4
lhaptx0724z 6r2m
27 Jan 23
Virpax Pharmaceuticals / Christopher Michael Chipman ownership change
8:30pm
SC 13G/A
16r26wy
26 Jan 23
Virpax Pharmaceuticals / Kepos Capital ownership change
4:05pm
SC 13G/A
cequ80kpn 5lrb28
10 Jan 23
Virpax Pharmaceuticals / SABBY MANAGEMENT ownership change
1:36pm
4
6kbhhssb6t64f 4zm0
4 Jan 23
Virpax Pharmaceuticals / Thani Jambulingam ownership change
8:30pm
4
zp2i2r
4 Jan 23
Virpax Pharmaceuticals / Eric Floyd ownership change
8:30pm
4
735fd336dikt7w irzk
4 Jan 23
Virpax Pharmaceuticals / Jerrold Sendrow ownership change
8:30pm
4
1l66nhyj
4 Jan 23
Virpax Pharmaceuticals / Michael F Dubin ownership change
8:30pm
4
ugr1q8 jb1tmhj
4 Jan 23
Virpax Pharmaceuticals / Vanila Singh ownership change
8:30pm
8-K
oi15y5 4l6qv7puc
29 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
S-8
g2niz 7ncg3ovo
22 Nov 22
Registration of securities for employees
4:06pm
8-K
300vsi3f5dgwsozjfg
9 Nov 22
Virpax Pharmaceuticals Reports 2022 Third Quarter Results
9:05am
EFFECT
urad8i8uc si
19 Oct 22
Notice of effectiveness
12:15am
CORRESP
yay dj3p2hw9ermhjew
14 Oct 22
Correspondence with SEC
12:00am
UPLOAD
xn1ccv6gsknsh3mz39
13 Oct 22
Letter from SEC
12:00am
S-3
vu1737klenn4lnqx
7 Oct 22
Shelf registration
5:01pm
8-K
sa28973r13e
15 Aug 22
Virpax Pharmaceuticals Reports 2022 Second Quarter Results and Recent Developments
9:10am
8-K
u1h 6utp16y53
25 Jul 22
Departure of Directors or Certain Officers
5:01pm